September is Prostate Cancer Awareness Month – a key time to bring attention to the disease that affects thousands of men each year. At mdxhealth, we are dedicated to raising awareness & improving patient outcomes for those at-risk for the disease. https://t.co/XeXkclB5vj
In one week, join this special live webinar with Dr. Scott Sellinger, MD as he covers the topic of Genomic Prostate Score (GPS) on Thursday, August 24th at 6:30 PM PST.
To register, email [email protected].
#advisor
Dr. Neal Shore presents how our Precision Cancer Pathway may help you minimize challenges you face while diagnosing and treating #ProstateCancer. Learn about Select mdx, Confirm mdx, and Genomic Prostate Score. Watch now: https://t.co/xA7c7PsNv2
#advisor
In case you missed it, last week UnitedHealthcare announced coverage for our Genomic Prostate Score (GPS) test! Thank you @UrologyTimes for sharing the news. Read the article here: https://t.co/n7ledahh0D
Eurofins Viracor ExPeCT™ anti-CD19 CAR T assay is NOW AVAILABLE.
• Assess current immune response
• Expansion and persistence of CAR T-cells
• Evaluate treatment decisions
#bmtsm#celltherapy#HemOnc#tandem23 @DrMiguelPerales @MediHumdani@TaniaJain11 @BldCancerDoc #BMT
Exciting news! UnitedHealthcare singles out mdxheath’s GPS test as its only commercially-covered test to risk-stratify men newly diagnosed with localized prostate cancer. Read more: https://t.co/IVth4z17vy
The GPS test is a genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions at the time of diagnosis. Learn more: https://t.co/AUro07PB5V
📢 LIVE WEBINAR ALERT | Today at 1:00pm CST
Dr. Clifford Miles reviews The University of Nebraska's Kidney Transplant program's strategy of using CMV inSIGHT T Cell Immunity testing to...... 👇 LEARN MORE BELOW
#Twitterx#NephTwitter#KidneyTransplant
Tailoring #CMV#prophylaxis in #kidneytransplant with Dr. Cliff Miles and Dr. Steve Kleiboeker. Tomorrow, Wednesday, December 14 @ 1 PM Central. Join us: https://t.co/1gJRBlEfyD
📢 WEBINAR ALERT – THIS WEEK!
Don't miss the LIVE Q&A with Dr. Clifford Miles, after the presentation. ✅ REGISTER NOW 👇
💊 1:00pm CST on Wednesday, Dec 14th.
#nephtwitter#CMV#TxPharm#Twitterx
💊 REGISTER for our webinar, “Tailoring CMV Prophylaxis Based on a CMV T Cell Immunity Panel Assay in Kidney Transplant Patients.” Presented by Dr. Clifford Miles, MD, FAST, on Dec 14th at 1pm CST.
✏️ Sign-up 👇
#kidneydonor#PharmD @cliffmiles #IDTwitter#CMV
Got to enjoy a beautiful night for @Chiefs football with my husband… & even better was bringing my daughter w/ for her first game! She had a 🏈! Thanks to @eurofinsviracor for offering opportunities like a chance to win 🎟! #employeeexperience#worklifebalance
Today the Epstein-Barr Virus inSIGHT™ T Cell Immunity test joins our portfolio of virus-specific cell mediated immunity tests.
The test measures the strength of CD4 & CD8 T Cell response to general, lytic & latent #EBV antigens.
#hsct#infectiousdisease#epsteinbarrvirus
⏲️ Our WEBINAR begins in 1 HOUR! 🕙 10am CT.
Join Drs., Abhay Dhand, Justin Rosenheck, & Kapil Saharia for CMV inSIGHT testing case study reviews.
⏳ “Addressing #CMV in Solid Organ Transplant Patients with CMV inSIGHT T Cell Immunity.”
#IDTwitter#transplanttwitter#TxPharmD
Webinar REMINDER ��� “Addressing CMV in Solid Organ Transplant Patients with CMV inSIGHT T Cell Immunity.”
📅 Tuesday Aug 30, 10am CT.
📣 Unique case studies from 3 doctors utilizing #CMV inSIGHT T Cell immunity for their SOT patients.
#MedTwitter #IDTwitter #Cytomegalovirus